← All supplements
Limited evidenceGut health

Lactobacillus Salivarius

A species native to the mouth and gut. Its small trial base is mostly dental — bad breath and periodontal measures — rather than digestive.

Evidence last reviewed: August 2026

What the science says

  • Oral malodor Limited evidence

    A double-blind, randomized, placebo-controlled crossover trial of L. salivarius WB21 tablets reported reduced oral malodor parameters. Small, single-center and short.

  • Periodontal health Limited evidence

    A double-blinded, placebo-controlled randomized trial of Lactobacillus as an adjunct in severe periodontitis reported improvement in clinical measures and halitosis, and a small study of the SGL03 strain found changes in periodontal and microbiological parameters. Both are adjuncts to dental treatment, not replacements.

  • Gut symptoms Limited evidence

    Despite being sold as a gut probiotic, L. salivarius has no adequately sized randomized trial for IBS, constipation or bloating on its own.

Dosage & safety

Studied doseOral trials used lozenges or tablets delivering roughly 1–6 billion CFU per day, dissolved in the mouth. Capsule doses for gut use are label-based rather than trial-based.
SafetyWell tolerated. For oral use, prefer sugar-free lozenges. Standard caution for live probiotics in severe immunosuppression, endocarditis risk or with central lines.

Scientific references

Where to buy

Referral link — this site may earn a commission on purchases.

Related in Gut health